NYSE: MSGSMadison Square Garden Sports Corp Stock
$187.45+1.30 (+0.7%)
Updated Apr 25, 2024
MSGS Price
$187.45
Fair Value Price
N/A
Market Cap
$4.49B
52 Week Low
$164.79
52 Week High
$215.79
P/E
116.43x
P/B
-13.23x
P/S
4.97x
PEG
6.1x
Dividend Yield
N/A
Revenue
$879.61M
Earnings
$38.53M
Gross Margin
36.9%
Operating Margin
11.62%
Profit Margin
4.4%
Debt to Equity
-5.03
Operating Cash Flow
$101M
Beta
0.78
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A
MSGS Overview
Madison Square Garden Sports Corp. operates as a professional sports company. Its portfolio of assets include the New York Knickerbockers of the National Basketball Association (NBA), and the New York Rangers of the National Hockey League; two development league teams, including the Hartford Wolf Pack of the American Hockey League, and the Westchester Knicks of the NBA G League; Knicks Gaming, an esports franchise; and esports teams. The company also owns two professional sports team performance centers, including the Madison Square Garden Training Center in Greenburgh, New York, and the CLG Performance Center in Los Angeles, California. Madison Square Garden Sports Corp. was formerly known as The Madison Square Garden Company. The company was founded in 1879 and is based in New York, New York.
Zen Score
–
Industry Average (21)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MSGS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MSGS ($187.45) is trading above its intrinsic value of $19.60, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MSGS is poor value based on its earnings relative to its share price (116.43x), compared to the US market average (40.97x)
P/E vs Market Valuation
MSGS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MSGS due diligence checks available for Premium users.
Be the first to know about important MSGS news, forecast changes, insider trades & much more!
MSGS News
Valuation
MSGS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
116.43x
Industry
35.98x
Market
40.97x
MSGS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MSGS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MSGS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-13.23x
Industry
2.65x
MSGS price to earnings growth (PEG)
For valuing profitable companies with growth potential
MSGS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MSGS's financial health
Profit margin
Revenue
$326.9M
Net Income
$14.2M
Profit Margin
4.4%
MSGS's Earnings (EBIT) of $102.24M... subscribe to Premium to read more.
Interest Coverage Financials
MSGS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.4B
Liabilities
$1.7B
Debt to equity
-5.03
MSGS's short-term liabilities ($560.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MSGS's long-term liabilities ($1.15B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MSGS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MSGS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$33.9M
Investing
-$3.5M
Financing
-$41.6M
MSGS's operating cash flow ($100.64M)... subscribe to Premium to read more.
Debt Coverage Financials
MSGS vs Entertainment Stocks
Madison Square Garden Sports Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.